(Total Views: 146)
Posted On: 03/31/2021 9:46:57 AM
Post# of 99190

$CURR CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline https://finance.yahoo.com/news/cure-pharmaceu...00116.html

